-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioid-treatments-chronic-pain-protocol.pdf
December 19, 2018 - ; some harms (including overdose risk) were dose-dependent. … Harms and Adverse Events
a. … harms, infections, cardiovascular events, cognitive harms, and
psychological harms (e.g., depression … (including overdose, substance use
disorder and misuse; other harms (including gastrointestinal harms … ,
cognitive harms, and psychological harms, including depression and suicidality).
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-236-maternal-fetal-child-outcomes-disposition-comments.pdf
April 15, 2021 - Insufficient Evidence of Maternal Harms. … Insufficient Evidence of Maternal Harms: Detailed
Synthesis. … Insufficient Evidence of Fetal, Infant, or Child
Harms. … or child
harms together. … Evidence of Fetal, Infant, or Child Harms:
Overview.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-reconstruction-mastectomy-protocol.pdf
April 09, 2020 - Specifically, the review will address the
(comparative) benefits and harms of:
• IBR versus AR (Key … We expect to summarize harms data
semiquantitatively (i.e., without meta-analysis). … We expect to primarily rely on reported within-study differences in effects (or harms). … of IBR and AR
• Relative clinical effects of IBR or IR before versus after chemotherapy
• Harms of … For KQ 6 (flap types for AR) we will also include in the
SoE tables harms to area of flap harvest.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-blood-transfusion-protocol-amendment.pdf
February 04, 2025 - Are the benefits and harms modified by:
i. … Are the benefits and harms modified by:
i. … Are the benefits and harms modified by:
i. … Are the benefits and harms modified by:
i. … Are the benefits and harms modified by:
i.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/plant-based-treatments-revised-protocol.pdf
March 29, 2023 - or better benefits for pain while avoiding potential unintended
consequences that could result in harms … Similarly, it is
important to identify harms and adverse effects of PBCs. … In adults with chronic pain, what are the harms of cannabinoids?
3. … We do not anticipate excluding observational studies assessing harms. … Systematic reviews will be used to identify primary studies and
5
to summarize harms of
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/deprescribing-protocol.pdf
July 01, 2023 - EHC Protocol: Making Healthcare Safer IV: Deprescribing to Reduce Medication Harms in Older Adults … Response Protocol
Project Title: Making Healthcare Safer IV: Deprescribing to
Reduce Medication Harms … What is the frequency and severity of harms associated with polypharmacy or potentially
inappropriate … For the purposes of this review, we will include evidence
published since 2019 on the benefits or harms … We will focus on the harms and
patient safety measures or indicators that are addressed in the studies
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-pancreas_research-protocol.pdf
August 09, 2013 - How are patient factors related to the harms of different imaging techniques?
b. … • We changed KQ 3 (harms) to “rates of harms” rather than simply “harms” to clarify the
focus on … how common the harms are, not simply what the possible harms are … Key Question 3 on the rates of procedural harms. … For harms (KQ 3), there is a statement in the Methods section that harms/complications
would be measured
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-urinary-retention_disposition-comments.pdf
September 15, 2014 - Disposition of Comments for Chronic Urinary Retention: Comparative Effectiveness and Harms of Treatments … Comments Report
Research Review Title: Chronic Urinary Retention: Comparative Effectiveness
and Harms … Chronic Urinary Retention: Comparative
Effectiveness and Harms of Treatments. … A few of our primary outcomes are also harms (UTI
and surgical interventions); strength of evidence … There were two key questions
examining the comparative effectiveness and harms,
respectively.
-
effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_1.pdf
April 01, 2020 - • Efficacy and harms of prescription drug
treatment for CATD:
– In adults with mild to moderate … or supplements for
cognition, function, and harms in CATD. … Evidence on the efficacy and harms of CATD
drugs had several limitations. … Harms reporting was poor. … Studies should systematically
collect data on potential harms of cognitive testing.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pwd-care-interventions-protocol.pdf
February 22, 2019 - While nondrug interventions are
generally presumed safe, few trials have reported information on their harms … in
People With Dementia (PWD)
• KQ1: For people with dementia (PWD), what are the benefits and harms … • KQ7: For people with dementia (PWD), what are the benefits and harms for care
interventions aimed … Societal costs, including caregiving
time/time spent on activities
Harms, including isolation, … for quality of life,
function, or non-BPSD symptoms in PWD
KQ 5-6: Evaluate benefits and harms of
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-blood-transfusion-protocol.pdf
September 24, 2024 - Are the benefits and harms modified by:
4
i. … Are the benefits and harms modified by:
i. … Are the benefits and harms modified by:
i. … Are the benefits and harms modified by:
i. … Are the benefits and harms modified by:
i.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_disposition-comments.pdf
June 07, 2013 - Overall
Benefits and Harms of
OCs
(pg.211) Page 245. Table 59. … Overall
Benefits and Harms of
OCs
(pg. 229) Figure 52 - Y axis is unclear. … Overall
Benefits and Harms of
OCs
(pg. 230, table 62?) … Overall
Benefits and Harms of
OCs
(pg. 251-253) Figure 81-84. … Overall
Benefits and Harms of
OCs
The future research sections are clear.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-future_research.pdf
October 26, 2012 - Harms
were not reported. … Harms were not reported.
ES-2
Table A. … Harms
were not reported. … Harms were not reported.
3
Table 1. … Harms were not reported.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_executive.pdf
April 01, 2012 - Objectives
This report summarizes the evidence on the comparative
efficacy, effectiveness, and harms … KQ 3: For patients with PsA, do drug therapies differ in
harms, tolerability, patient adherence, or … KQ 4: What are the comparative benefits and harms of
drug therapies for PsA in subgroups of patients … Summary of findings
Key Comparisons
Efficacy and Effectiveness
Strength of Evidence Grade
Harms … Information generally was insufficient for the comparative
harms, tolerability, adverse events, and
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-256-telehealth-women-preventive-services-executive-summary.pdf
June 01, 2022 - -
efficacy, post-traumatic stress disorder, and safety behaviors (low SOE), and
unclear evidence on harms … utilization.
• Studies did not adequately evaluate factors related to access, health equity, or
potential harms … Data on harms was extremely limited for
IPV and not addressed in studies of contraceptive care. … Number of
Studies;* Study
Design;
Participants (n) Overall Effect
Strength
of
Evidence
Harms … family planning or STI counseling or evaluated factors related to access, health equity, or
potential harms
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-evidence-summary.pdf
December 01, 2020 - Evidence did not suggest an
increased risk of serious harms for any intervention, though studies were … not designed to
assess serious harms. … Evidence on how benefits or harms varied in subgroups
was lacking. … Additionally, trials
were not designed to evaluate how benefits and harms varied in subgroups. … acute pain
on non-pain outcomes; effects of therapies on long-term outcomes; and how benefits and
harms
-
effectivehealthcare.ahrq.gov/sites/default/files/assessing-the-risk-of-bias_draft-report.pdf
June 02, 2011 - (CONSORT Harms extension, 2004).
24
For a
detailed explanation of terms associated with harms please … Although reviewers
recognize the importance of harms outcomes, harms are generally ignored in quality … The McMaster University Harms scale (McHarm) tool was developed specifically for
evaluating harms and … Was the mode of harms collection specified as ACTIVE?
6. … Did the study specify WHO collected the harms?
8.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/allergy-seasonal_executive.pdf
July 01, 2013 - The quality of harms reporting was assessed using the
USPSTF rating, with specific attention to both … , underreporting or inconsistent reporting
of harms.
6
Two reviewers independently assessed the … Efficacy Outcome Harms Outcome
1. … Agreed-upon reporting
standards for effectiveness and harms outcomes are
needed. … McMaster Quality Assessment Scale
of Harms (McHarm) for Primary Studies.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_clinician.pdf
September 01, 2014 - Spectrum Disorder
Key Clinical Issue
What evidence is available regarding the effectiveness, benefits, and harms … many other interventions,
the evidence is insufficient to permit an estimate of their
benefits or harms … This does not mean that these interventions
are not associated with benefits or harms but that further … other medical interventions, including serotonin-
reuptake inhibitors and stimulant medications.
Harms … Note Regarding Possible Harms
Other than for risperidone and aripiprazole, there was not
enough evidence
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0263_12-28-2007.pdf
January 01, 2007 - fibrosis, including
the potential benefits (growth outcomes, decreased hospitalizations, etc.) and harms … What is the evidence for harms of rhGH in CF patients? … The harms of rhGH will be an important aspect of the review conducted within the EHC Program.